Last reviewed · How we verify
Nicotine Lozenges
Nicotine lozenges work by releasing nicotine into the bloodstream to help manage withdrawal symptoms and cravings associated with smoking cessation.
Nicotine lozenges work by releasing nicotine into the bloodstream to help manage withdrawal symptoms and cravings associated with smoking cessation. Used for Smoking cessation.
At a glance
| Generic name | Nicotine Lozenges |
|---|---|
| Also known as | Commit nicotine lozenge, NRT |
| Sponsor | GlaxoSmithKline |
| Drug class | Nicotine replacement therapy |
| Modality | Small molecule |
| Therapeutic area | Addiction |
| Phase | Phase 3 |
Mechanism of action
Nicotine lozenges are designed to provide a controlled release of nicotine, which helps to alleviate withdrawal symptoms and cravings. This can make it easier for individuals to quit smoking by reducing the discomfort associated with nicotine withdrawal.
Approved indications
- Smoking cessation
Common side effects
- Hiccups
- Nausea
- Headache
- Dizziness
- Insomnia
Key clinical trials
- Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers (NA)
- Smoking Cessation and Menstrual Cycle Phase (PHASE4)
- Cytisine vs Nicotine Replacement Therapy (NA)
- ACT Lung Health Intervention: Phase Two (NA)
- iCanQuit Smoking Cessation Among Hispanic Adults (PHASE3)
- Varenicline for Smoking Reduction in Veterans Not Ready To Quit (PHASE4)
- Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients (NA)
- E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |